Menu principal
  • Our laboratory

    QUI SOMMES-NOUS ?

    CEVIDRA, un établissement pharmaceutique au service des professionnels de santé.

    En savoir +

    NOS VALEURS

    Le Laboratoire CEVIDRA se voue quotidiennement à l’amélioration de la santé et du bien-être des personnes souffrant...

    En savoir +

    NOS ENGAGEMENTS

    Cevidra s'attache à répondre aux besoins des ses partenaires et consommateurs avec des produits fiables et de qualité.

    En savoir +

  • Nos services

    IMPORTATION / EXPORTATION

    Distribution efficace et rapide des médicaments et du petit et du gros matériel médicale.

    En savoir +

    DEPOSITAIRE / EXPLOITANT

    Autorisé stocker des médicaments, produits, objets ou articles dont l’entreprise n’est pas propriétaire en vue de leur distribution.

    En savoir +

    AFFAIRES REGLEMENTAIRES

    Grâce à notre personnel qualifié, le Laboratoire Cevidra conseille et aide les sociétés.

    En savoir +

    PHARMACOVIGILANCE / MATERIOVIGILANCE

    Pour garantir la qualité et la sécurité dans la chaîne d'approvisionnement, nous appliquons les normes de bonnes pratiques de distribution.

    En savoir +

  • Our medications

    MEDICAMENTS SOUS ATUc

    Les médicaments que le laboratoire CEVIDRA commercialise sont des traitements nouveaux, curatifs ou palliatifs, dans des niches thérapeutiques.

    En savoir +

    MEDICAMENTS SOUS ATUn

    Lorsque le médicament sous ATU fait preuve d’une efficacité établie par l’ANSM le laboratoire CEVIDRA enregistre toujours sous le contrôle de l’ANSM le médicament en ATU de Cohorte puis en AMM.

    En savoir +

    Médicaments AMM

    Le laboratoire CEVIDRA assure en concertation avec le fabricant du médicament les processus d’enregistrement et de remboursement auprès des autorités compétentes.

    En savoir +

  • Dispositifs médicaux

    RESPIRATION

    nasanita

    NASANITA® est un dilatateur pour améliorer la respiration nasale. En savoir plus

    ANTI-RONFLEMENT

    ANTI-RONFLEMENT

    NOZOVENT® : Trouvez le produit adapté à votre type de ronflement et retrouvez un sommeil paisible. En savoir plus

    NEZ SEC OU IRRITE

    nozoil

    NOZOIL® : Un spray nasal à base d'huile de sésame naturelle que hydrate, décongestionne et apaise pour tout en douceur. En savoir plus

    HYGIÈNE DU NEZ

    Rhinicur

    DOUCHE NASALE RHINICUR®  : C'est un moyen simple et naturel de se nettoyer le nez. En savoir plus SPRAY ET GOUTTES NASALES RHINICUR® : Un soin naturel pour les bébés et les adultes. En savoir plus

    CONTENTION

    FOXEASYSOCKS

    FOX EASY SOCKS® : Pour enfiler et ôter facilement les chaussettes et bas de contention. En savoir plus

  • Telemedicine, tele-expertise and remote diagnostics solutions

    DERMATOSCOPE À LED ET LUMIÈRE UV

    DERMATOSCOPE

    Dermatoscope UV MIC-FI WiFi est un dermatoscope numérique portable et avec transmission Wi-Fi, avec lumière blanche et UV. En savoir plus

    DERMATOSCOPE À FILTRE POLARISANT

    DERMATOSCOPE

    Dermatoscope Mic-Fi avec filtre polarisant est un microscope numérique avec transmission Wi-Fi. En savoir plus

    CAMERA NUMERIQUE

    Camera numerique

    Caméra numérique MIC-FI Wifi est une camera Wi-Fi, pour instruments et dispositifs optiques à monture C... En savoir plus

    OTOSCOPE

    Otoscope

    Otoscope MIC-FI wifi est un otoscope numérique avec transmission Wi-Fi. En savoir plus

  • Contactez nous

NOS MEDICAMENTS

The CEVIDRA Laboratory works with innovative pharmaceutical laboratories based in France, Europe, North America or Australia and provides medicines to more than 800 healthcare institutions to treat, prevent or diagnose serious or rare diseases for which There is still no appropriate treatment benefiting from a marketing authorization in France.

The drugs that the CEVIDRA Laboratory markets are new treatments, curative or palliative, in therapeutic niches. These medications are often indispensable for the patient. When the new molecules or new dosage forms are available in marketing authorization or show an efficacy, from the Phase II or Phase III clinical study for the best molecules, the CEVIDRA Laboratory imports and Commercializes the medicinal product with the authorization of ANSM (the National Agency for the Safety of Medicines and Health Products). These drugs are often available in other countries in Europe through programs called "Named Patient Medicine", "Early Access Program" or "Compassionate Use".

Today, the CEVIDRA Laboratory is involved in the following therapeutic areas :

  • Cardiology
  • Infectious Diseases / parasitology
  • Neurology
  • Metabolism
  • pneumonology
  • Urology / Nephrology

Laboratoire CEVIDRA for Physicians, Hospital Pharmacists and Patients

The CEVIDRA Laboratory provides hospitals, doctors and pharmacists, and their patients with medicines that have not been approved by the National Agency for the Safety of Medicines and Health Products (ANSM).
These medicines are evaluated scientifically and technically for their quality, efficiency and safety of use. These medicines are only available in hospitals and in the framework of registered ATUs (Temporary Use Authorizations), cohort ATUs or authorization to import in exceptional cases in the event of a stock-out.

The CEVIDRA laboratory provides physicians and hospital pharmacists with information on new molecules or new galenic forms available. These new molecules are developed and produced in France, Europe or elsewhere in the world by pharmaceutical laboratories specialized in research on rare diseases.

Our pharmaceutical know-how with hospitals

In the framework of simple consultations, open or restricted invitations to tender, negotiated or adapted procedures, the laboratory cell of the CEVIDRA Laboratory is able to respond to requests from healthcare establishments, hospitals and clinics and to provide:

  • A wide range of medicines
  • Best rates for the majority of ATU drugs from Europe, America or Australia
  • A quick response to requests for information from the medical profession
  • A supply as soon as possible







TEMPORARY AUTHORIZATION FOR USE (ATUn)

The Temporary Use Exemption (ATUn) is the French equivalent of "Named Patient Medicine" or "Early Access Program".

These medicines which do not yet have a marketing authorization in France are imported with an ATU (Temporary Use Authorization) status under the control of ANSM. The CEVIDRA Laboratory distributes them under the status of Temporary Authorization of Nominative Use or ATUn. The CEVIDRA Laboratory does not have the right to communicate on these medicines, but doctors and pharmacists can find the information on the ANSM (National Agency for the Safety of Medicines and Health Products) website: specialties allowed in the framework Of nominative ATUs.

 

 




TEMPORARY AUTHORIZATION FOR THE USE OF COHORT (ATUc)

The Temporary Cohort Use Authorization (ATUc) is the French equivalent of "Compassionate Use" or "Early Access Program".

When the ATUn drug demonstrates efficacy established by ANSM or when a new molecule is available and no suitable treatment exists, the CEVIDRA Laboratory records, under the control and validation of ANSM, the Medication in ATUc (Temporary Cohort Use Authorization).
Within the framework of a cohort ATU, the CEVIDRA Laboratory establishes Therapeutic Use and Information Collection Protocols (PUT) to organize the provision of medicines to patients and allow continuous monitoring of possible adverse effects (predictable Or unexpected) health products. These protocols for therapeutic use are validated by the ANSM (the National Agency for the Safety of Medicines and Health Products).

The CEVIDRA Laboratory manages Temporary Cohort Usage Authorizations (ATUc) on a daily basis and in accordance with the dossiers validated by the National Agency for the Safety of Medicines and Health Products (ANSM) since inclusion and follow-up of patients up to To the collection of data and the preparation of periodic synthesis reports.

 

 





MARKETING AUTHORIZATION (MA)

The CEVIDRA Laboratory ensures, in consultation with the manufacturer of the medicinal product, the processes of registering the medicinal product and obtaining reimbursement prices by participating in the preparation and submission of dossiers and in negotiations with the competent authorities.

The CEVIDRA Laboratory is responsible for the distribution and use of medicines with a marketing authorization (Marketing Authorization), which controls advertising and promotes medicinal products to specialists in accordance with the rules established by the Health Authorities.





PRODUCT WITH SPECIAL IMPORT AUTHORIZATION

Information from the Kela Pharma Laboratory on the DIPHANTOINE specialty in France.



















Laboratoire CEVIDRA map 45 Boulevard Marcel Pagnol 06130 Grasse - FRANCE tel +33 (0)4 93 70 58 31 mail contact@cevidra.com